Kess Avrohom J.

Vice Chmn. & Chief Legal Officer sells 6,735 shares (6.7K) of TRV at $308.78 for $2,079,640.04; stock near 52-week highs.

Kess Avrohom J. sold 6,735 shares at $308.78 on 2026-04-28, reducing holdings by -12.1% vs pre-transaction levels. The sale occurred near the stock's 52-week high of $312.03 (-3.1% from peak), and the current price of $302.25 sits 30-day +3.6% and 90-day +6.3% above the transaction date. At the same ticker (TRV), his prior 3 measurable sells all posted negative 90-day returns (-1.3%, -4.2%, -4.0%, -3.6%), establishing a 100% well-timed rate over his TRV-specific history. His cross-ticker track record shows 4 prior sells with a 100% well-timed rate overall, though with modest average 90-day decline of -0.6%. TRAVELERS carries fundamental strength with $11.9B revenue, $1.7B net income, 5.2% annual revenue growth, and a P/E of 8.45, suggesting stable underlying business. The sale's placement near 52-week highs combined with his consistent pattern of selling before subsequent declines warrants tracking of whether this transaction signals another well-timed exit or represents a departure from his established pattern.

Kess (Vice Chmn & Chief Legal Off) sells 4,756 TRV shares at $300.44; prior 3 TRV sells all well-timed at 90-day mark.

Kess sold 4,756 shares at $300.44 on 2026-02-20, reducing his holdings by 8.6% from 55,618 to 50,862 shares. The timing context is notable: his prior three trades at TRV (all sales on 2025-05-29) showed a consistent pattern of well-timed execution at the 90-day mark, with negative 90-day returns of -0.3%, -0.7%, and -0.9% respectively. His cross-ticker track record on sells also reflects a 100.00% well-timed rate across 3 prior sales, though with modest average returns of -3.9% at 30 days and -0.6% at 90 days. The stock currently trades at $305.39, having recovered +10.0% over the past 30 days and +4.0% over 90 days from the sale price. TRV trades at a P/E of 9.22 with recent quarterly net income of $1.9B on $12.5B revenue, suggesting a profitable, steady business that has not registered obvious distress signals.

Director Kess Avrohom J. purchases 17,800 shares of VRNS at $22.29; holdings rise to 49,403 shares as stock trades -58.5% from 52-week high

Kess Avrohom J. purchased 17,800 shares at $22.29 on 2026-02-06, expanding his position by 56.3% to 49,403 shares total. The transaction occurs while VRNS stock is trading -58.5% from its 52-week high of $63.31 and down 25.5% over the past 30 days. At VRNS specifically, Kess's prior two open-market purchases (2024-02-12 and 2023-08-04) showed mixed results: one declined 14.0% at the 90-day mark, while the other gained 12.2%. Notably, a cluster of 3 other insiders also bought VRNS within the past 14 days, suggesting coordinated interest in the name. The company remains unprofitable (net income $-29.9M) despite 13.2% annual revenue growth, creating a contrarian timing signal in a significantly depressed stock price.

Vice Chairman & Chief Legal Officer Kess Avrohom J. sold 23,434 shares for $6,419,363.89 on 2025-05-29 at blended avg $273.93

Kess Avrohom J. executed 3 separate sales totaling 23,434 shares for $6,419,363.89 at prices ranging from $273.09 to $274.73, reducing his holdings by 32.6% from 71,821 to 48,387 shares. The transaction occurred near the company's 52-week high of $275.88, with the stock currently at $275.70 and having appreciated 4.4% over the trailing 30 days and 6.7% over 90 days. His cross-ticker track record shows mixed timing outcomes (50% win rate on 90-day returns averaging -0.9%), providing limited predictive context for this specific action. The sale size and concentration in a single filing warrant observation given his senior legal and governance role, though the post-transaction holding of 48,387 shares indicates substantial remaining exposure to the company.